Skip to main content
. 2019 May 17;10(6):901–906. doi: 10.1039/c9md00124g

Table 1. MIC (minimum inhibitory concentrations) of fluoroquinolone derivatives.

Species Strain MIC (μg mL–1)
Ciprofloxacin 1 Cipro-N3 2 Cipro-NBD 3 Cipro-DMACA 4
Staphylococcus aureus ATCC 25923 0.125–0.5 0.25 32–≥64 16
Bacillus subtillis ATCC 6051 0.313–0.06 0.06–0.25 8 4
Enterococcus faecium ATCC 35667 1–8 16–≥64 32 32–≥64
Klebsiella pneumoniae ATCC 13883 0.015–0.06 0.125–0.25 8–16 4–32
Acinetobacter baumannii ATCC 19606 0.5–1 0.25–0.5 32–≥64 32
Pseudomonas aeruginosa ATCC 27853 0.25–1 8–≥64 32–≥64 32–≥64
PAO750 PAO397 Δ a ≤0.25 32–≥64 4 2–8
Escherichia coli ATCC 25922 ≤0.004 0.06–0.25 8 2
MB4902 ΔlpxC ≤0.004 0.25–1 1–4 2
MB5747 ΔtolC ≤0.004 0.25–1 0.125–0.25 0.5–1
MB5746 ΔlpxC, ΔtolC ≤0.004 0.25–1 0.06–0.125 0.5–1

aDelta efflux pump mutant: ΔmexAB-oprM, ΔmexCD-oprJ, ΔmexEF-oprN, ΔmexJKL, ΔmexXY, ΔopmH, ΔpscC.